IP Financing is a $3 billion dollar market that’s still in its first stages. It’s been widely used in the pharmaceutical and biotech sector, and more and more businesses from other industries are now using their IP assets to take advantage of this funding option.

money plan

IP can be collateral or security for debt finance. It  can also be used for seeking equity from friends, family, private investors venture capitalists, specialized banks and some times even from regular banks.

IP creates an immediate asset to the balance sheet of your small or mid-sized business. It offers incredible flexibility in making your business attractive to investors or financing institutions, especially if your business doesn’t qualify for traditional business loans or lines of credit.In the last few years, a number of new IP funding options have appeared, including collateralized loans, IP auctions, royalty secularization, as a conduit between investors and IP owners.



All types of IP, including copyrights, trademarks, patents and even trade secrets are used for IP financing. Depending on the loan amount, your IP collateral can include part or all of your IP assets. To qualify for the loan, your IP must be valuable, which is determined by it’s use in the marketplace, either from revenue generating products or services, or royalty revenues from licensing agreements.

You can learn more about IP financing from my interview with IP Metrics, an IP valuation firm. I spoke with the principles, David Drews – President, David Martin – Managing Principal and Fernando Torres –  Chief Economist. During this interview we discussed how IP financing works, what you must do to qualify, why many business owners overlook this option, and some key insight on what types of IP are best suited for IP funding. You can visit their website at http://ipmetrics.net/ for more information about the company and its services.

David Drews
Daryl Martin
Fernando Torres
Mr. Brenner has over 30 years IP management and licensing experience with various industries including consumer products, food, entertainment, software,health technology, medical devices and digital media. He has led international licensing programs as both licensee and licensor, and through consulting projects focused on strategy and management, outbound / inbound licensing initiatives, and IP audits and due diligence.. He has developed and managed deals with Fortune 1000 companies including Universal Studios, Fox Interactive, Sony Pictures, Dow, Cargill, SmithKline Glaxo, Ranir, Coca Cola, Kellogg’s, Hasbro, Mattel, and others. He is a public speaker and published writer, and has taught classes at the university level. His speaking events have included UC Irvine, Tritech/SBDC, Irvine Chamber, Fast Start Studios, ICFO Investors Conference, San Diego Investment Conference, Westlaw Legal Center (NYC), National Speakers Association, and the Hong Kong FilmArt Expo. He has written several articles on licensing intellectual property which have appeared in the Licensing Journal, Intellectual Property Magazine, and License India.

Leave a Reply

Your email address will not be published. Required fields are marked *